Retrospective proteomic studies, including those which aim to elucidate the molecular
mechanisms driving cancer, require the assembly and characterization of substantial patient …

Lung cancer is the most common cause of cancer-related death worldwide, less than 7% of
patients survive 10 years following diagnosis across all stages of lung cancer. Late stage of …

An apparatus for mass spectrometry and/or ion mobility spectrometry is disclosed
comprising a first device arranged and adapted to generate aerosol, smoke or vapor from a …

Lung cancer is a disease with a very low 5-year survival rate (6–13%) worldwide. The most
frequently diagnosed histological type of this cancer is non-small cell lung cancer (NSCLC) …

Lung cancer is the leading cause of cancer-related death worldwide. Both diagnostic and
prognostic biomarkers are urgently needed to increase patient survival. In this study, we …

Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and is a fast
progressive disease when left untreated. Identification of potential biomarkers in NSCLC is …

Protein sialylation participates many biological processes in a linkage-specific manner, and
aberrant sialylation has been associated with many malignant diseases. Mass spectrometry …

Introduction: Lung cancer and related diseases have been one of the most common causes
of deaths worldwide. Genomic-based biomarkers may hardly reflect the underlying dynamic …

Lung cancer is the leading cause of cancer-related deaths worldwide with lung
adenocarcinoma (LUAD) being the most common type. Genomic studies of LUAD have …

Gel-forming mucins are macromolecules produced by goblet cells and responsible for the
mucus gel formation. Changes in goblet cell density and in gel-forming mucin production …